DNA Script
Latest round
- Series C
Last raised
- Jan 2022
Total raised
- $327M
Investors
- 26
About DNA Script
Based in Le Kremlin-Bicêtre, France, and founded in 2014 by Sylvain Gariel, Thomas Ybert, and Xavier Godron, DNA Script Inc. develops and provides template-free enzymatic technology for synthetic DNA (Deoxyribonucleic acid) production. DNA Script SAS’s product line includes the Syntax system, Syntax 60-cycle kit, 96 oligos, and Syntax software suite. The Syntax system is powered by Enzymatic DNA Synthesis (EDS) technology is a DNA printer that enables the on-demand synthesis of custom DNA oligos in a benchtop solution. Syntax 60-cycle kit, 96 oligos is also powered with EDS technology for template-free synthesis. The Syntax software suite is an intuitive, remote interface for seamless planning and automation. DNA Script has developed an alternative to traditional DNA synthesis, which is Enzymatic DNA Synthesis (EDS) that allows technology to be feasible for the labs with the Syntax System.01 million.
Who invested in DNA Script
26 investors across 5 rounds
See all investors in DNA Script
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DNA Script
Who invested in DNA Script?
DNA Script has 26 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DNA Script raised?
DNA Script has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did DNA Script last raise money?
DNA Script's most recent round on record is a Series C, in Jan 2022.
What does DNA Script do?
Based in Le Kremlin-Bicêtre, France, and founded in 2014 by Sylvain Gariel, Thomas Ybert, and Xavier Godron, DNA Script Inc.
Where is DNA Script headquartered?
DNA Script is headquartered in France.
Which VCs invest in companies like DNA Script?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at DNA Script's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like DNA Script? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.